BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34596477)

  • 1. Comparative analysis of the long-term outcomes of segmentectomy and lobectomy for stage IA1 lung adenocarcinoma in patients with or without previous malignancy of other organs: a population-based study.
    Bai W; Zhang J; Wang Y; Zhou M; Liu L; Wang G; Zhao K; Gao X; Li S
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):215-228. PubMed ID: 34596477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study.
    Li F; Zhao Y; Yuan L; Wang S; Mao Y
    J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
    Wang L; Ge L; You S; Liu Y; Ren Y
    J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A propensity score matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma.
    Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Mar; 7(12):13880-5. PubMed ID: 26871600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublobectomy for stage IA1-2 invasive lung adenocarcinoma with consolidation tumor ratio ≤ 0.25.
    Qi YF; Qiu ZB; Zhang C; Fu R; Yang XW; Chu XP; Chen ZH; Yang XN; Wu YL; Zhong WZ
    Thorac Cancer; 2022 Nov; 13(22):3174-3182. PubMed ID: 36208139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
    Kagimoto A; Tsutani Y; Kushitani K; Kai Y; Kambara T; Miyata Y; Takeshima Y; Okada M
    Ann Thorac Surg; 2021 Sep; 112(3):935-943. PubMed ID: 33144104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.
    Shao S; Song G; Wang Y; Yi T; Li S; Chen F; Li Y; Liu X; Han B; Liu Y
    Front Oncol; 2022; 12():946800. PubMed ID: 36081555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer.
    Zhang Y; Yuan C; Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Apr; 7(14):19081-6. PubMed ID: 26934652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy on the patients with non-small cell lung cancer: a propensity score matching study.
    Hwang Y; Kang CH; Kim HS; Jeon JH; Park IK; Kim YT
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):273-8. PubMed ID: 25406426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmentectomy versus lobectomy for deep clinical T1a-bN0M0 non-small cell lung cancer.
    Li Z; He Z; Xu W; Wang J; Zhu Q; Chen L; Wu W
    Eur J Surg Oncol; 2023 Oct; 49(10):106946. PubMed ID: 37286427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-Dimensional Guided Cone-Shaped Segmentectomy Versus Lobectomy for Small-sized Non-Small Cell Lung Cancer in the Middle Third of the Lung Field.
    Li Z; Xu W; Wang J; Zhu Q; Wu W; Chen L
    Ann Surg Oncol; 2023 Oct; 30(11):6684-6692. PubMed ID: 37378847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
    Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
    Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
    Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.
    Lu D; Yang J; Liu X; Feng S; Dong X; Shi X; Zhai J; Mai S; Jiang J; Wang Z; Wu H; Cai K
    Cancer Med; 2020 May; 9(10):3455-3462. PubMed ID: 32207885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.